China Pharma Holdings Inc
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin inje… Read more
China Pharma Holdings Inc (CPHI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.028x
Based on the latest financial reports, China Pharma Holdings Inc (CPHI) has a cash flow conversion efficiency ratio of -0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-236.99K) by net assets ($8.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
China Pharma Holdings Inc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how China Pharma Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
China Pharma Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Pharma Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Rohartindo Nusantara Luas T
JK:TOOL
|
0.004x |
|
EdgeMode Inc.
PINK:EDGM
|
0.016x |
|
Vnsteel Vicasa JSC
VN:VCA
|
N/A |
|
Summit Minerals Ltd
AU:SUM
|
-0.048x |
|
BIOGEN (IDP.SG)
STU:IDP
|
0.057x |
|
Mamba Exploration Ltd
AU:M24
|
-0.144x |
|
BGT Corporation Public Company Limited
BK:BGT
|
0.114x |
|
TEXAS INSTRUMENTS - Dusseldorf Stock Exchang
DU:TII
|
0.100x |
Annual Cash Flow Conversion Efficiency for China Pharma Holdings Inc (2001–2024)
The table below shows the annual cash flow conversion efficiency of China Pharma Holdings Inc from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $7.75 Million | $-466.36K | -0.060x | +35.87% |
| 2023-12-31 | $7.45 Million | $-699.69K | -0.094x | +1.68% |
| 2022-12-31 | $4.29 Million | $-409.55K | -0.095x | -129.95% |
| 2021-12-31 | $6.02 Million | $-249.84K | -0.042x | -686.36% |
| 2020-12-31 | $8.00 Million | $-42.26K | -0.005x | -108.02% |
| 2019-12-31 | $9.24 Million | $608.31K | 0.066x | +58.21% |
| 2018-12-31 | $30.20 Million | $1.26 Million | 0.042x | +113.12% |
| 2017-12-31 | $43.07 Million | $841.22K | 0.020x | -60.27% |
| 2016-12-31 | $58.91 Million | $2.90 Million | 0.049x | +6.59% |
| 2015-12-31 | $72.64 Million | $3.35 Million | 0.046x | +7.17% |
| 2014-12-31 | $106.25 Million | $4.57 Million | 0.043x | -33.45% |
| 2013-12-31 | $132.94 Million | $8.60 Million | 0.065x | +163.53% |
| 2012-12-31 | $148.52 Million | $3.64 Million | 0.025x | -33.25% |
| 2011-12-31 | $142.48 Million | $5.24 Million | 0.037x | -44.32% |
| 2010-12-31 | $117.94 Million | $7.79 Million | 0.066x | -44.07% |
| 2009-12-31 | $90.40 Million | $10.67 Million | 0.118x | +26.02% |
| 2008-12-31 | $69.87 Million | $6.54 Million | 0.094x | +32.90% |
| 2007-12-31 | $39.76 Million | $2.80 Million | 0.070x | +184.62% |
| 2006-12-31 | $20.85 Million | $-1.74 Million | -0.083x | -115.89% |
| 2005-12-31 | $-68.32K | $-35.81K | 0.524x | 0.00% |
| 2004-12-31 | $-68.32K | $-35.81K | 0.524x | +313.11% |
| 2003-12-31 | $-733.96K | $-93.13K | 0.127x | -75.98% |
| 2002-12-31 | $-566.35K | $-299.20K | 0.528x | 0.00% |
| 2001-12-31 | $-566.35K | $-299.20K | 0.528x | -- |